Virus-like particles (VLPs) are efficient tools for boosting mRNA-induced antibodies
A.-C. S. Vogt, L. Jörg, B. Martina, P. S. Krenger, X. Chang, A. Zeltins, M. Vogel, M. O. Mohsen, M. F. Bachmann
This study compares antibody responses from homologous and heterologous prime-boost vaccination strategies using mRNA and VLP-based vaccines against SARS-CoV-2.
bioRxiv · Dec 20, 2021Immunology